Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus is a research paper published in Cell Reports Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR000423
NIAID NIH HHS
Grant: R01 AI147846
NIH HHS
Grant: P51 OD010425
NCATS NIH HHS
Grant: UL1 TR002319
National Institutes of Health
Grant: 3UL1TR000423-07S1
Institute of Translational Health Sciences
National Institutes of Health
Grant: 3P51OD010425-53S1
Washington National Primate Research Center
National Institutes of Health
Grant: 5R01AI147846-02
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
National Institutes of Health
FWCI
2.21
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Additional file 1 of A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Additional file 1 of A broad wastewater screening and clinical data surveillance for virus-related diseases in the metropolitan Detroit area in Michigan
Additional file 1 of A broad wastewater screening and clinical data surveillance for virus-related diseases in the metropolitan Detroit area in Michigan